Abstract: The present invention relates to the use of oligonucleotides having modified nucleobases to inhibit gene expression and/or replication of viruses in a subject. The modified nucleobases may be mercapto-modified bases or hydroxy-modified nucleobases. It is contemplated that the oligonucleotides further comprise a nuclease complex which enhances anti-viral activity of the oligonucleotides.
Type:
Application
Filed:
November 5, 2008
Publication date:
July 14, 2011
Applicant:
BALTIC TECHNOLOGY DEVELPMENT, LTD.
Inventors:
Mart Saarma, Andres Merits, Mati Karelson